Showing results (1231-1240 of 5,345) with videos related to

Sort By:
Pageof 535
Japanese Journal of Clinical Oncology|April 28, 2025
Treatment outcomes and failure patterns in postoperative radiotherapy for major salivary gland carcinomaShota Miyoshi, Ikuno Nishibuchi, Hiroki Ochi, et al.
Japanese Journal of Clinical Oncology|November 8, 2025
Real-world outcomes of prostate-specific membrane antigen-targeted radioligand therapy in Japanese patients with metastatic castration-resistant prostate cancerYuki Enei, Takafumi Yanagisawa, Hidetoshi Kuruma, et al.
Japanese Journal of Clinical Oncology|October 22, 2025
An inadequate number of first-line chemotherapy cycles provides poor survival outcomes in patients with metastatic urothelial carcinoma receiving avelumab maintenance: results from the chu-shikoku Japan urological consortiumSatoshi Katayama, Takehiro Iwata, Shingo Nishimura, et al.
Japanese Journal of Clinical Oncology|October 21, 2025
Remarkable response of gastric adenocarcinoma with FGFR2-TRIM44 fusion to pemigatinib: a case reportMiho Fujiwara, Kiichiro Ninomiya, Emi Chikuie, et al.
Japanese Journal of Clinical Oncology|September 30, 2025
Impact of starting dose of tyrosine kinase inhibitors on outcomes following combination therapy of immune checkpoint inhibitors with tyrosine kinase inhibitors for previously untreated advanced renal cell carcinomaHiroki Ishihara, Koichi Nishimura, Yuki Nemoto, et al.
Japanese Journal of Clinical Oncology|September 7, 2025
Amrubicin monotherapy for refractory, relapsed, small cell lung cancer in elderly patientsMasashi Takemoto, Shiori Kinoshita, Kazuki Yamada, et al.
Japanese Journal of Clinical Oncology|August 12, 2025
Tasurgratinib (E7090) for cholangiocarcinoma with fibroblast growth factor receptor 2 fusions/rearrangements: a multicenter, open-label, Phase 2 studyLin Shen, Huaxin Duan, Takamichi Kuwahara, et al.
Japanese Journal of Clinical Oncology|August 12, 2025
Evaluation of ovarian cancer prognosis by nomogram model based on prospective cohort studyHongmei Li, Qianjie Xu, Yuliang Yuan, et al.
Japanese Journal of Clinical Oncology|February 13, 2026
Zolbetuximab-based chemotherapy in CLDN18.2-positive gastric cancer: real-world tumor response and early albumin kineticsYuki Ushimaru, Kazuyoshi Yamamoto, Toshihiro Kudo, et al.
Japanese Journal of Clinical Oncology|November 14, 2022
Clinical features of CDK4/6 inhibitor-related interstitial lung disease in patients with breast cancer: a case series studyChikako Funasaka, Yoichi Naito, Shota Kusuhara, et al.
Pageof 535